Stanmore implants Dodd into CFO role
Eric Dodd leaves Antisoma CFO role for Stanmore
ORTHOPAEDIC IMPLANTS manufacturer Stanmore Implants has appointed Eric Dodd as CFO.
He has more than 19 years’ financial experience, including roles at GlaxoSmithKline and as group FD of Morse. He qualified as a chartered accountant at Deloitte having attained a manufacturing degree at Loughborough University, and an MBA from the London Business School.
He joins Stanmore from Antisoma, where he has spent three years as CFO.
“His finance experience and understanding of the sector will be invaluable as we enter new markets and expand our product offering,” said Brian Steer, executive chairman.
“He is an excellent addition to the board and I look forward to working with him as we take the company into its next phase of growth.”
For more companies and markets data visit the Share Price Centre